Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INTORACT: Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa in Advanced RCC
NCT00631371Phase 3Completed
- Sponsor
- Pfizer
- Start
- Apr 2008
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 30
01
Overview
A Phase 3 trial of temsirolimus in renal cell carcinoma (RCC), sponsored by Pfizer. Started Apr 2008; status: completed.
02
Drugs
temsirolimus
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00631371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00631371.